Transcranial magnetic stimulation (TMS), commonly referred to as treatment-resistant depression (TRD), has come to be recognized as a viable non-invasive therapeutic option for refractory depression. The complexity of TRD, a disorder marked by resistance to traditional therapies, is examined in this research, along with how TMS can provide a fresh solution to the problem. TMS attempts to modify neural activity in specific brain areas linked to mood control by using focused electromagnetic pulses. We look at the mechanism of TMS, its effectiveness, safety profile, and considerations for customized therapy. Even though TMS has the ability to reduce depression symptoms, further study is still necessary due to the complex interaction of variables that impact how well treatments work. The growing story of optimism and cooperation between medical professionals, researchers, and patients looking for relief from the weight of resistant depression is captured. The overall result founded that there are direct and significant link of transcranial magnetic stimulation as a treatment for refractory depression.